Postpartum Hemorrhage — Acute Management

Key Points

• Treat postpartum hemorrhage according to bleeding severity and physiology, not visual estimation alone.
• Use the four Ts framework: Tone, Trauma, Tissue, and Thrombin.
• Uterine atony requires immediate massage and uterotonic therapy while other causes are assessed.
• Uterotonic selection must account for asthma, hypertension, and other contraindications.
• Give tranexamic acid early when clinically indicated and within the evidence-supported postpartum window.
• Massive hemorrhage requires warmed blood products, calcium monitoring and replacement, and active prevention of hypothermia.
• A firm uterus with ongoing bleeding should prompt a search for laceration, retained tissue, surgical bleeding, or coagulopathy.
• Escalate early to mechanical, interventional radiology, or operative control when bleeding continues.

Algorithm

1. Activate the obstetric hemorrhage team and quantify ongoing blood loss while assessing hemodynamics.
2. Obtain large-bore IV access, CBC, coagulation studies, fibrinogen, type and crossmatch, and shock markers as severity warrants.
3. Massage the uterus and administer oxytocin for suspected atony.
4. Add an appropriate second-line uterotonic while respecting asthma and hypertension contraindications.
5. Administer tranexamic acid early when postpartum hemorrhage is diagnosed and no contraindication outweighs benefit.
6. Initiate balanced transfusion and massive transfusion protocol when shock or uncontrolled major bleeding is present; warm products and correct calcium.
7. Identify and directly treat trauma, retained tissue, inversion, rupture, placental pathology, or coagulopathy.
8. Escalate to balloon tamponade or other nonsurgical device, embolization, operative control, or hysterectomy without avoidable delay.

Clinical Synopsis & Reasoning

Postpartum hemorrhage can occur after vaginal or cesarean delivery and may be primary, within the first 24 hours, or delayed. The classic etiologic framework is the four Ts: Tone, Trauma, Tissue, and Thrombin. Uterine atony is the most common cause, but retained placenta, laceration, uterine inversion or rupture, placenta accreta spectrum, and coagulopathy must be actively considered. A soft enlarged uterus suggests atony, whereas persistent brisk bleeding with a firm uterus should increase concern for genital tract trauma or another source.

The severity of bleeding is determined by physiology and trajectory rather than a single estimated volume. Tachycardia, hypotension, narrow pulse pressure, altered mental status, oliguria, pallor, or rising lactate may indicate important shock. Pregnancy-related increases in circulating blood volume can delay hypotension, so waiting for classic shock can postpone lifesaving treatment. Quantitative blood loss is preferable to visual estimation when feasible, but resuscitation should begin immediately when ongoing hemorrhage is evident.

Evaluate the uterus, placenta, birth canal, surgical field, and coagulation status in parallel. Obtain CBC, fibrinogen, PT/INR, aPTT, type and crossmatch, metabolic panel, ionized calcium, blood gas or lactate in substantial hemorrhage, and point-of-care coagulation testing if available. Falling fibrinogen can be an early marker of severe obstetric hemorrhage. Consider amniotic fluid embolism, placental abruption, sepsis, and DIC when bleeding is accompanied by sudden coagulopathy or cardiopulmonary collapse.

Treatment Strategy & Disposition

Activate the obstetric hemorrhage protocol early. Establish large-bore IV access, warm the patient, provide oxygen when indicated, and begin balanced blood-component resuscitation for hemorrhagic shock rather than relying on large volumes of crystalloid. Perform uterine massage and give oxytocin promptly for suspected atony. Additional uterotonics are selected according to contraindications: methylergonovine is generally avoided in severe hypertension or preeclampsia, and carboprost is generally avoided in significant asthma. Misoprostol can be used as an additional uterotonic in many protocols.

Tranexamic acid reduces death due to bleeding when administered early for clinically diagnosed postpartum hemorrhage and should be given as soon as possible within 3 hours of birth when indicated, typically 1 g IV over about 10 minutes, with a second dose considered for ongoing or recurrent bleeding according to protocol. It does not replace uterotonics, repair, placental removal, or definitive hemorrhage control. Correct hypocalcemia, hypothermia, and severe coagulopathy during massive transfusion.

When medications and massage do not control bleeding, escalate rapidly to uterine balloon or other nonsurgical hemorrhage-control devices when appropriate, uterine artery embolization when the patient is stable enough and resources are available, operative repair, uterine compression sutures, arterial ligation, or hysterectomy. Retained placenta requires removal, lacerations require repair, and inversion requires immediate reduction with obstetric expertise. Persistent hemorrhage should trigger massive transfusion and surgical pathways early rather than sequentially exhausting low-yield measures.

Epidemiology / Risk Factors

• Postpartum hemorrhage is a leading cause of maternal morbidity and preventable maternal death worldwide.
• Risk factors include uterine overdistention, prolonged or augmented labor, multiple gestation, macrosomia, chorioamnionitis, prior postpartum hemorrhage, abnormal placentation, operative delivery, and coagulopathy, but many cases occur without clear risk factors.
• Uterine atony accounts for the largest proportion of primary postpartum hemorrhage.
• Placenta accreta spectrum substantially increases risk for massive hemorrhage and often requires planned multidisciplinary delivery.
• Standardized obstetric hemorrhage bundles improve readiness, recognition, response, and transfusion coordination.

Investigations

Uterotonics (Examples)

Pharmacology

Prognosis / Complications

• Prompt recognition and coordinated hemorrhage control usually result in good maternal recovery.
• Risk rises sharply with delayed source control, severe shock, DIC, hypothermia, acidosis, and massive transfusion.
• Severe hemorrhage can cause acute kidney injury, myocardial ischemia, pituitary ischemia, transfusion complications, and psychological trauma.
• Peripartum hysterectomy is lifesaving when hemorrhage cannot otherwise be controlled but has major reproductive and emotional consequences.
• Patients with prior postpartum hemorrhage have increased recurrence risk in future pregnancies and should have anticipatory planning.

Patient Education / Counseling

• Patients recovering from major hemorrhage should receive clear explanations of what caused the bleeding, what procedures or blood products were required, and implications for future pregnancy.
• Counsel about anemia symptoms, iron replacement, and follow-up hemoglobin testing when indicated.
• Give urgent return precautions for heavy bleeding, syncope, dyspnea, chest pain, fever, worsening pelvic pain, or weakness after discharge.
• Discuss emotional recovery and screen for trauma-related symptoms when the event was severe or involved emergency surgery.
• Future pregnancies should include early obstetric review of hemorrhage history and placental risk.
• If hysterectomy or major fertility-impacting intervention occurred, offer appropriate reproductive counseling and support.

Notes

Postpartum hemorrhage management works best as simultaneous resuscitation and source control. The correct response to ongoing shock is not to keep cycling through uterotonics while delaying repair, tamponade, embolization, or surgery when the cause demands those interventions.

Hemorrhage protocols should anticipate calcium depletion, hypothermia, dilutional coagulopathy, and fibrinogen loss during large-volume transfusion.

References

1. ACOG Postpartum Hemorrhage Practice Bulletin — Link
2. ACOG Clinical Practice Update on Nonsurgical Hemorrhage-Control Devices — Link